We leveraged tissue from that cohort to elucidate the effects of PD-1 inhibition on immune cell populations in ccRCC and correlate the evolving immune milieu with anti-PD-1 response. The gene discussed is PDCD1; the disease is nonpapillary renal cell carcinoma.